Following positive pre-pivotal trial results, Trinity Biotech is concentrating on its CGM technology while pursuing operational efficiencies to strengthen its financial position. The press release ...

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

In other recent news, Trinity Biotech has made significant strides with its continuous glucose monitoring (CGM) system, reporting a 35% improvement in Mean Absolute Relative Difference (MARD ...

In other recent news, Trinity Biotech has secured an additional $4 million in debt financing from Perceptive Advisors to advance its continuous glucose monitoring (CGM) technology and transformation ...

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech's board and management have determined that CGM technology and ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...